Hrt Financial »

Nurix Therapeutics shares owned by Hrt Financial

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Hrt Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $890k 86k 10.32
2023-06-30 $284k 28k 9.99

More positions owned by Hrt Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Linde SHS (LIN)
Apple (AAPL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
CRH Ord (CRH)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Align Technology (ALGN)
Spdr S&p 500 Etf Tr Put
Home Depot (HD)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Hrt Financial

Top funds holding Nurix Therapeutics

Baker Bros. Advisors
Redmile Group
ARK Investment Management
Vanguard Group
T. Rowe Price Associates
Daniel D. Thurber
Dimensional Fund Advisors
Candriam Luxembourg S.C.A.
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Millennium Management
Bessemer
Arrowpoint Asset Management
Taddei, Ludwig & Associates
Goldman Sachs Group

View all funds holding Nurix Therapeutics